Elevar Therapeutics
Salt Lake City
About Elevar Therapeutics
LSK BioPartners, Inc (dba LSK BioPharma) is a privately-held pharmaceutical company based in Salt Lake City, Utah with offices in South San Francisco (and Pangyo, South Korea). LSK BioPharma (LSKB) specializes in clinical development of promising therapies for unmet medical needs in cancer. LSKB is developing two proprietary drug candidates; rivoceranib (Apatinib), a VEGFR-2 inhibitor which has demonstrated clinical efficacy in a variety of solid tumors and a BTK/JAK3 inhibitor with the potential to treat hematologic malignancies and rheumatoid arthritis as an immunosuppressive agent. LSKB holds worldwide rights for rivoceranib excluding China and has partnered for development and marketing in South Korea.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $20.0M
- Last round: Series Unknown (Jul 2018)
- Website: elevartherapeutics.com
- Phone: (801) 303-7440
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical, Product Design
Social Profiles
Canonical: https://fsome.com/organization/elevar-therapeutics-38164 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.